Covid-19 boosters: improving patient information leaflets

Affiliations

Comment

Peter R McCartney. BMJ. 2023.

. 2023 Sep 21:382:2100.

doi: 10.1136/bmj.p2100.

No abstract available

Conflict of interest statement

Competing interests: None declared.

Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses.
Andersson NW, Thiesson EM, Baum U, Pihlström N, Starrfelt J, Faksová K, Poukka E, Lund LC, Hansen CH, Aakjær M, Kjær J, Cohet C, Goossens M, Andersen M, Hallas J, Meijerink H, Ljung R, Hviid A. Andersson NW, et al. BMJ. 2023 Jul 24;382:e074325. doi: 10.1136/bmj-2022-074325. BMJ. 2023. PMID: 37487623 Free PMC article.
Why older adults can continue to benefit from covid-19 boosters.
[No authors listed] [No authors listed] BMJ. 2023 Jul 25;382:1662. doi: 10.1136/bmj.p1662. BMJ. 2023. PMID: 37491033 No abstract available.